Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,049 | 536 | 566 | 7,211 | 3,887 |
| Gross Profit | 1,049 | 536 | 566 | 7,211 | 3,887 |
| Operating Expenses | 33,671 | 34,650 | 31,939 | 28,568 | 28,635 |
| Operating Income | -32,622 | -34,114 | -31,373 | -21,357 | -24,748 |
| Interest Expense | 958 | 952 | 959 | 852 | 982 |
| Other Income | 3,693 | 3,405 | 2,190 | 2,596 | 2,733 |
| Pre-tax Income | -29,887 | -31,661 | -30,142 | -19,613 | -22,997 |
| Net Income Continuous | -29,887 | -31,661 | -30,142 | -19,613 | -22,997 |
| Net Income | $-29,887 | $-31,661 | $-30,142 | $-19,613 | $-22,997 |
| EPS Basic Total Ops | -0.25 | -0.28 | -0.32 | 0.32 | -0.24 |
| EPS Basic Continuous Ops | -0.25 | -0.28 | -0.32 | 0.32 | -0.24 |
| EPS Diluted Total Ops | -0.25 | -0.28 | -0.32 | 0.32 | -0.24 |
| EPS Diluted Continuous Ops | -0.25 | -0.28 | -0.32 | 0.32 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.28 | -0.32 | N/A | N/A |
| EBITDA(a) | $-31,595 | $-32,998 | $-30,119 | $-20,077 | $-23,462 |